Bellamy's Australia Ltd: Is it boom to bust for baby formula retailers?

Bellamy's Australia Ltd (ASX:BAL), a2 Milk Company Ltd (ASX:A2M) and Bega Cheese Ltd (ASX:BGA) all have big stakes in the baby formula industry, which one is the best buy?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The baby formula industry has enjoyed an amazing run. The share prices of Bellamy's Australia Ltd (ASX: BAL) and a2 Milk Company Ltd (ASX: A2M) have grown 451% and 331% respectively since April 2015. Bega Cheese Ltd's (ASX: BGA) share price hasn't moved in this time.

There has been growing demand in China for safe, high-quality baby formula products which these companies provide. Not long ago there was so much demand that people were buying products in Australia and selling them overseas for a large mark-up, leaving retailers' shelves bare and imposing a purchase limit per customer.

However, maybe the market had pencilled in too much growth and now reality is catching up with the share prices. Retailers are no longer facing major shortages of baby formula; perhaps the supply and demand curve will change to be in the consumers' favour?

Possible obstacles

There are two possible obstacles for the baby formula related companies.

The first is that the Chinese government is trying to crack down on the "grey market" goods being shipped into China unofficially.

The other obstacle is competition. There are many huge corporations in the food industry that would want a slice of this booming market. Nestle and others may swoop in to take more market share.

Blackmores Limited (ASX: BKL) is also launching its own formula to leverage off the success of its other products in Asia, directly competing with a2 Milk Company and Bellamy's. This Blackmores product will be supplied by Bega.

Outlook

With China recently increasing its one child policy to two in 2015, there could be a baby boom. This could resulting in more formula being required. As long as these Australian companies can grow their sales directly in China, it will unlock a large direct market for them.

The populations of South East Asia and Australia continue to grow, so as long as the average number of births remains steady (or increases), it's pretty safe to assume volume demand for baby formula will continue to grow.

Valuation

It's hard to know what the right price is to pay for these growing businesses. Bellamy's is trading at 24x FY16's earnings, a2 Milk Company is trading at 33x FY16's earnings and Bega is trading at 25x FY16's earnings (source:Commsec).

These are pretty high multiples for any industry.

When you take into account FY18's estimated earnings, the prices look more reasonable; Bellamy's at 12.5x, a2 Milk Company at 17.7x, and Bega at 17.3x.

Dividend

Bellamy's and Bega are not known for being big dividend payers; Bellamy's has a grossed up yield of 1.48%, and Bega's is 2.64%. However, in the years to come the dividend may grow substantially. A2 Milk Company doesn't pay a dividend (yet).

Foolish takeaway

It's always important to be mindful of the price you pay when buying growth stocks. Bellamy's shares are still 16% down from the all-time high in December 2015. But long-term investors could still get solid returns from these companies.

Bellamy's would be my pick out of the three for Foolish investors who want to buy into this baby formula trend. It's purely focused on baby formula production and looks promising for long term growth at the current price. A2 Milk Company and Bega have slower growing areas of their businesses which could dilute the overall speed of growth.

Motley Fool contributor Tristan Harrison doesn’t own shares in any companies mentioned. The Motley Fool Australia owns shares in Bellamy's and a2Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »